ArticleJournal of cancer research and clinical oncology2023

Clinical outcomes with atezolizumab plus bevacizumab or lenvatinib in patients with hepatocellular carcinoma: a multicenter real-world study.

Mara Persano et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.